Showing results (41-50 of 148) with videos related to
Sort By:
Pageof 15
Genetics|June 1, 1986
Suppressors of the ras2 mutation of Saccharomyces cerevisiaeJ F Cannon, J B Gibbs, K TatchellThe Journal of Biological Chemistry|July 25, 1992
Retinoblastoma protein binding properties are dependent on 4 cysteine residues in the protein binding pocketS M Stirdivant, J D Ahern, A Oliff, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985
Friend murine leukemia virus-immortalized myeloid cells are converted into tumorigenic cell lines by Abelson leukemia virusA Oliff, O Agranovsky, M D McKinney, et al.Gastroenterology Research|April 4, 2022
Isolated Enteric Myeloid Sarcoma as a Rare Etiology of Small Bowel Obstruction in a Young Female PatientNagwa Abou-Ghanem, Eltaib Saad, Ira A Oliff, et al.Breast Cancer Research and Treatment|January 1, 1996
Farnesyltransferase inhibitors and anti-Ras therapyJ B Gibbs, N E Kohl, K S Koblan, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1984
Autophosphorylation of v-Ha-ras p21 is modulated by amino acid residue 12J B Gibbs, R W Ellis, E M ScolnickMolecular and Cellular Biology|April 1, 1990
Transforming ras proteins accelerate hormone-induced maturation and stimulate cyclic AMP phosphodiesterase in Xenopus oocytesS E Sadler, J L Maller, J B GibbsMolecular and Cellular Biology|August 1, 1991
Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic RasD W Stacey, L A Feig, J B GibbsJournal of the National Cancer Institute|June 15, 1988
Tumor necrosis factor not detectable in patients with clinical cancer cachexiaS H Socher, D Martinez, J B Craig, et al.Blood|July 1, 1989
Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude miceR A Johnson, T A Waddelow, J Caro, et al.Pageof 15